How to use crenezumab to delay or prevent the onset of Alzheimer's disease

JP2025525331A5Pending Publication Date: 2026-06-23GENENTECH INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
GENENTECH INC
Filing Date
2023-06-13
Publication Date
2026-06-23

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

Provided herein are methods of treating human patients with familial Alzheimer's disease by administering a humanized monoclonal anti-amyloid beta (Aβ) antibody, resulting in a delay in the onset of symptoms and / or a slowing of cognitive decline.
Need to check novelty before this filing date? Find Prior Art